<DOC>
	<DOC>NCT01941563</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy and safety of SI-6603 (condoliase) in patients with lumbar disc herniation.</brief_summary>
	<brief_title>A Study of SI-6603 in Patients With Lumbar Disc Herniation</brief_title>
	<detailed_description />
	<mesh_term>Spinal Diseases</mesh_term>
	<mesh_term>Intervertebral Disc Displacement</mesh_term>
	<mesh_term>Intervertebral Disc Degeneration</mesh_term>
	<criteria>Patients with lumbar disc herniation (L4L5 or L5S1) as assessed by MRI and clinical symptoms corresponding to position of the impaired nerve root. Patients assessed as positive in the SLR test. Patients with sciatica in either leg. Patients with no improvement from conservative treatment Patients who have 2 or more lumbar disc herniations as assessed by MRI. Patients in whom a rupture into the posterior longitudinal ligament is identified by MRI. Patients who have received spinal injection, epidural injection, nerve block within 3 weeks prior to the time of informed consent. Patients who have undergone lumbar operation, or lumbar percutaneous nucleotomy or lumbar intradiscal therapies</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>